Literature DB >> 10966484

Role of Ras isoforms in the stimulated proliferation of human renal fibroblasts in primary culture.

Claire C Sharpe1, Mark E C Dockrell1, Mazhar I Noor1, Brett P Monia2, Bruce M Hendry1.   

Abstract

The proliferation of renal fibroblasts is implicated in the pathophysiologic processes of renal fibrosis. Many of the growth factors involved in proliferation are known to activate intracellular signaling pathways that converge on Ras monomeric GTPases. Although three ras family genes exist, their functional specificity is not yet known. Using antisense oligonucleotides, a role for Kirsten (Ki)-Ras in the stimulated proliferation of a primate renal fibroblast cell line was previously demonstrated. This study examines Ras in primary cultures of adult human renal fibroblasts. Using reverse transcription-PCR, mRNA for Harvey (Ha)-ras, Ki(4B)-ras, and neural (N)-ras, but not Ki(4A)-ras, were detected. Antisense oligonucleotides targeting Ha-, Ki-, and N-ras mRNA, which were used for liposomal transfection at 100 to 200 nM, were demonstrated to be active and isoform-specific in quantitative reverse transcription-PCR assays. Cellular Ras protein levels, as estimated using isoform-specific monoclonal antibodies, indicated that Ki-Ras was the predominantly expressed isoform (>95% of total Ras protein) under both serum-containing and serum-free conditions, with N- and Ha-Ras being detected in small amounts. Consistent with this finding, the antisense oligonucleotide directed against Ki-Ras reduced total cellular Ras levels by >70%, whereas Ha-Ras, N-Ras, and control oligonucleotides had no significant effect. Proliferation of oligonucleotide-transfected cells was measured using epidermal growth factor (EGF) and serum stimulation. The Ki-Ras oligonucleotide at 100 nM reduced serum-stimulated proliferation by >50% and EGF-stimulated proliferation by 25%, compared with data obtained with the control oligonucleotide (P: < 0. 01). The N-Ras oligonucleotide was not active, compared with the control oligonucleotide. The Ha-Ras oligonucleotide was not significantly active at 100 nM but reduced serum-stimulated proliferation by 13% and EGF-stimulated growth by 40% at 200 nM (P: < 0.01). These results demonstrate that Ki-Ras(4B) is the predominantly expressed Ras isoform in human renal fibroblasts in primary culture and is important for both serum- and EGF-stimulated proliferation. Ha-Ras appears to be expressed at low levels but may also play a distinct role in stimulated proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966484     DOI: 10.1681/ASN.V1191600

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Ras isoform abundance and signalling in human cancer cell lines.

Authors:  J Omerovic; D E Hammond; M J Clague; I A Prior
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

2.  Resident mesenchymal cells and fibrosis.

Authors:  Nicol Hutchison; Cécile Fligny; Jeremy S Duffield
Journal:  Biochim Biophys Acta       Date:  2012-12-04

3.  Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation.

Authors:  María T Grande; Miguel Arévalo; Alejandro Núñez; Jorge B Cannata-Andía; Eugenio Santos; José M López-Novoa
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

4.  Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy.

Authors:  Lucy J Newbury; Jui-Hui Wang; Gene Hung; Bruce M Hendry; Claire C Sharpe
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

Review 5.  Dissecting the Involvement of Ras GTPases in Kidney Fibrosis.

Authors:  José M Muñoz-Félix; Carlos Martínez-Salgado
Journal:  Genes (Basel)       Date:  2021-05-24       Impact factor: 4.096

6.  Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.

Authors:  Takahiro Nishio; Yukinori Koyama; Xiao Liu; Sara B Rosenthal; Gen Yamamoto; Hiroaki Fuji; Jacopo Baglieri; Na Li; Laura N Brenner; Keiko Iwaisako; Kojiro Taura; James S Hagood; Nicholas F LaRusso; Tapan K Bera; Ira Pastan; David A Brenner; Tatiana Kisseleva
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 12.779

7.  Silencing genes in the kidney: antisense or RNA interference?

Authors:  Jia-Hui Wang; Bruce M Hendry; Claire C Sharpe
Journal:  Nephrol Dial Transplant       Date:  2008-03-07       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.